Joan Mancuso
@joanmancusombc.bsky.social
#PatientAdvocate living with #metastaticbreastcancer since 2007 (treatment pause since 2020). Presenter, panelist and author for #breastcancer. Former managing editor.
Pinned
Joan Mancuso
@joanmancusombc.bsky.social
· Jun 26
The MBCRC Advocate Researcher Program (MARP): connecting advocates and researchers as collaborative partners in cancer research - npj Breast Cancer
npj Breast Cancer - The MBCRC Advocate Researcher Program (MARP): connecting advocates and researchers as collaborative partners in cancer research
www.nature.com
It is an honor to collaborate with excellent advocates, clinicians and scientists on an ongoing project to develop long-term, bi-directional relationships with early career researchers, and what we learned.
www.nature.com/articles/s41...
www.nature.com/articles/s41...
Reposted by Joan Mancuso
Meta-analysis: #SGLT2 inhibitors slow kidney decline consistently across CKD severity and albuminuria range, supporting their routine use for kidney health.
#KidneyWK @asnkidney.bsky.social
ja.ma/3JqqaMi
#KidneyWK @asnkidney.bsky.social
ja.ma/3JqqaMi
November 7, 2025 at 11:35 PM
Meta-analysis: #SGLT2 inhibitors slow kidney decline consistently across CKD severity and albuminuria range, supporting their routine use for kidney health.
#KidneyWK @asnkidney.bsky.social
ja.ma/3JqqaMi
#KidneyWK @asnkidney.bsky.social
ja.ma/3JqqaMi
Reposted by Joan Mancuso
🎗️ October is #BreastCancerAwarenessMonth!
💗The MRS honors survivors and researchers, including our MRS president, Dr. Alana Welm, who recently received Innovator of the Year award for advancing & sharing patient-derived breast cancer models enabling precision medicine. bit.ly/493BMiL
💗The MRS honors survivors and researchers, including our MRS president, Dr. Alana Welm, who recently received Innovator of the Year award for advancing & sharing patient-derived breast cancer models enabling precision medicine. bit.ly/493BMiL
October 24, 2025 at 6:14 PM
🎗️ October is #BreastCancerAwarenessMonth!
💗The MRS honors survivors and researchers, including our MRS president, Dr. Alana Welm, who recently received Innovator of the Year award for advancing & sharing patient-derived breast cancer models enabling precision medicine. bit.ly/493BMiL
💗The MRS honors survivors and researchers, including our MRS president, Dr. Alana Welm, who recently received Innovator of the Year award for advancing & sharing patient-derived breast cancer models enabling precision medicine. bit.ly/493BMiL
Reposted by Joan Mancuso
The Week in Cancer News: Some COVID-19 vaccines may strengthen immunotherapy's effectiveness, an antibody-drug conjugate and an immune checkpoint inhibitor improve survival for patients with bladder cancer, and more. buff.ly/Rt5VfsP
October 24, 2025 at 8:37 PM
The Week in Cancer News: Some COVID-19 vaccines may strengthen immunotherapy's effectiveness, an antibody-drug conjugate and an immune checkpoint inhibitor improve survival for patients with bladder cancer, and more. buff.ly/Rt5VfsP
Reposted by Joan Mancuso
📢 #ACCFIT & #ACCEarlyCareer: Are you passionate about improving CV care in rural communities? Help lead impactful, community-based research & drive progress in ❤️ health. Apply for the Thad & Gerry Waites Rural CV Research Fellowship by Oct. 22! 🔗 bit.ly/473XX5v
#ACCHealthEquity #CardioSky #MedSky
#ACCHealthEquity #CardioSky #MedSky
October 20, 2025 at 5:03 PM
📢 #ACCFIT & #ACCEarlyCareer: Are you passionate about improving CV care in rural communities? Help lead impactful, community-based research & drive progress in ❤️ health. Apply for the Thad & Gerry Waites Rural CV Research Fellowship by Oct. 22! 🔗 bit.ly/473XX5v
#ACCHealthEquity #CardioSky #MedSky
#ACCHealthEquity #CardioSky #MedSky
Reposted by Joan Mancuso
Approximately 5 million adult #Medicaid beneficiaries risk losing coverage due to HR 1's work requirements, with a substantial portion having chronic conditions, particularly among those aged 50 to 64.
ja.ma/4mQpVHW
ja.ma/4mQpVHW
October 7, 2025 at 1:00 PM
Approximately 5 million adult #Medicaid beneficiaries risk losing coverage due to HR 1's work requirements, with a substantial portion having chronic conditions, particularly among those aged 50 to 64.
ja.ma/4mQpVHW
ja.ma/4mQpVHW
Reposted by Joan Mancuso
Reposted by Joan Mancuso
2026 PhD recruitment is now open.
As well as our main PhD recruitment, which is open to all, we are pleased to be offering scholarships for candidates of Black or mixed Black heritage. Learn more and apply on our website:
www.crick.ac.uk/careers-stud...
As well as our main PhD recruitment, which is open to all, we are pleased to be offering scholarships for candidates of Black or mixed Black heritage. Learn more and apply on our website:
www.crick.ac.uk/careers-stud...
PhD student recruitment
PhD recruitment information.
www.crick.ac.uk
October 7, 2025 at 3:14 PM
2026 PhD recruitment is now open.
As well as our main PhD recruitment, which is open to all, we are pleased to be offering scholarships for candidates of Black or mixed Black heritage. Learn more and apply on our website:
www.crick.ac.uk/careers-stud...
As well as our main PhD recruitment, which is open to all, we are pleased to be offering scholarships for candidates of Black or mixed Black heritage. Learn more and apply on our website:
www.crick.ac.uk/careers-stud...
Reposted by Joan Mancuso
New open-access article in Supportive Care in Cancer: Evaluating the role of montelukast on doxorubicin-induced cardiotoxicity in breast cancer patients
link.springer.com/article/10.1...
#SuppOnc #bcsm
link.springer.com/article/10.1...
#SuppOnc #bcsm
October 7, 2025 at 3:22 PM
New open-access article in Supportive Care in Cancer: Evaluating the role of montelukast on doxorubicin-induced cardiotoxicity in breast cancer patients
link.springer.com/article/10.1...
#SuppOnc #bcsm
link.springer.com/article/10.1...
#SuppOnc #bcsm
Reposted by Joan Mancuso
Think you're "OK" because you had a negative mammogram? Nothing showed up on my mammogram yet #Inflammatorybreastcancer was growing! Don't rely on a mammogram for #IBC....keep pushing for answers! www.ibcresearch.org
October 6, 2025 at 8:38 PM
Think you're "OK" because you had a negative mammogram? Nothing showed up on my mammogram yet #Inflammatorybreastcancer was growing! Don't rely on a mammogram for #IBC....keep pushing for answers! www.ibcresearch.org
Reposted by Joan Mancuso
Super honored to be visiting @danafarber.bsky.social to deliver the 2025 Harriet Tischler Memorial Lecture hosted by the amazing Nelly Polyak. Thanks for the invitation!
seminarsinoncology.dana-farber.org
seminarsinoncology.dana-farber.org
October 6, 2025 at 10:46 PM
Super honored to be visiting @danafarber.bsky.social to deliver the 2025 Harriet Tischler Memorial Lecture hosted by the amazing Nelly Polyak. Thanks for the invitation!
seminarsinoncology.dana-farber.org
seminarsinoncology.dana-farber.org
Reposted by Joan Mancuso
What a fantastic day of learning courtesy of @mskcme.bsky.social @mskcancercenter.bsky.social !
Can’t wait for tomorrow’s sessions!
Thank you @billyrosaphd.bsky.social & your planning team 🎉!
Can’t wait for tomorrow’s sessions!
Thank you @billyrosaphd.bsky.social & your planning team 🎉!
October 6, 2025 at 11:17 PM
What a fantastic day of learning courtesy of @mskcme.bsky.social @mskcancercenter.bsky.social !
Can’t wait for tomorrow’s sessions!
Thank you @billyrosaphd.bsky.social & your planning team 🎉!
Can’t wait for tomorrow’s sessions!
Thank you @billyrosaphd.bsky.social & your planning team 🎉!
Reposted by Joan Mancuso
💬 Viewpoint: The One Big Beautiful Bill Act's federal loan caps may exacerbate socioeconomic disparities in #MedEd, worsening the Matthew Effect and hindering diversity and equity within the physician workforce.
ja.ma/46SxxUs
ja.ma/46SxxUs
October 4, 2025 at 11:00 AM
💬 Viewpoint: The One Big Beautiful Bill Act's federal loan caps may exacerbate socioeconomic disparities in #MedEd, worsening the Matthew Effect and hindering diversity and equity within the physician workforce.
ja.ma/46SxxUs
ja.ma/46SxxUs
Reposted by Joan Mancuso
Johns Hopkins sophomore student Florin Selaru develops a new scheme to deconvolve colors in histological sections for digital pathology.
It greatly outperforms traditional linear color deconvolution.
Congrats Florin!
Read his paper here: www.biorxiv.org/content/10.1...
It greatly outperforms traditional linear color deconvolution.
Congrats Florin!
Read his paper here: www.biorxiv.org/content/10.1...
October 4, 2025 at 1:05 PM
Johns Hopkins sophomore student Florin Selaru develops a new scheme to deconvolve colors in histological sections for digital pathology.
It greatly outperforms traditional linear color deconvolution.
Congrats Florin!
Read his paper here: www.biorxiv.org/content/10.1...
It greatly outperforms traditional linear color deconvolution.
Congrats Florin!
Read his paper here: www.biorxiv.org/content/10.1...
Reposted by Joan Mancuso
An estimated 61% of U.S. children have been enrolled in #Medicaid or CHIP and 42% have experienced periods of uninsurance by age 18, with insurance disruptions being more common in states with restrictive Medicaid policies.
ja.ma/474AItj
ja.ma/474AItj
October 4, 2025 at 3:00 PM
An estimated 61% of U.S. children have been enrolled in #Medicaid or CHIP and 42% have experienced periods of uninsurance by age 18, with insurance disruptions being more common in states with restrictive Medicaid policies.
ja.ma/474AItj
ja.ma/474AItj
Reposted by Joan Mancuso
I am super excited to be presenting information about inflammatory breast cancer to the sister’s network breast. Cancer summit for black women today in Houston, Texas! IBC is more common in black women: outcome disparities can be erased w/ prompt diagnosis & guideline driven care!! #thinkibc #bcsm
October 4, 2025 at 4:36 PM
Reposted by Joan Mancuso
9-month-old Mohamat died of malaria in Cameroon. Before U.S. aid cuts, he likely would have survived. Malaria deaths are rising after years of progress. Abrupt and irresponsible budget cuts can have deadly consequences.
Babies' deaths in Cameroon show how US aid cuts curtail malaria fight
Nine-month-old baby Mohamat burned with fever for three days before his family took him to the closest health centre in northern Cameroon, but it was too late. He died of malaria that day.
www.reuters.com
October 4, 2025 at 6:37 PM
9-month-old Mohamat died of malaria in Cameroon. Before U.S. aid cuts, he likely would have survived. Malaria deaths are rising after years of progress. Abrupt and irresponsible budget cuts can have deadly consequences.
Reposted by Joan Mancuso
Are 90% of cancer-related deaths due to metastasis? Apparently the overuse of this percentage in reviews has created confusion and questioning of whether this is true. The answer, which is as always cancer type dependent, may be in these references that also people claim they cannot find.
September 28, 2025 at 4:39 PM
Are 90% of cancer-related deaths due to metastasis? Apparently the overuse of this percentage in reviews has created confusion and questioning of whether this is true. The answer, which is as always cancer type dependent, may be in these references that also people claim they cannot find.
Reposted by Joan Mancuso
Bridging the Gap between Genomics and Social Determinants:
Melissa B. Davis, Brittany D. Jenkins-Lord, and Michelle J. Lee addressed this topic in an #AACRdisp25 plenary session chaired by Christopher R. Flowers.
@MeliD32 @ChrisRFlowersMD
Melissa B. Davis, Brittany D. Jenkins-Lord, and Michelle J. Lee addressed this topic in an #AACRdisp25 plenary session chaired by Christopher R. Flowers.
@MeliD32 @ChrisRFlowersMD
September 20, 2025 at 1:19 PM
Bridging the Gap between Genomics and Social Determinants:
Melissa B. Davis, Brittany D. Jenkins-Lord, and Michelle J. Lee addressed this topic in an #AACRdisp25 plenary session chaired by Christopher R. Flowers.
@MeliD32 @ChrisRFlowersMD
Melissa B. Davis, Brittany D. Jenkins-Lord, and Michelle J. Lee addressed this topic in an #AACRdisp25 plenary session chaired by Christopher R. Flowers.
@MeliD32 @ChrisRFlowersMD
Reposted by Joan Mancuso
In the latest episode of the JAMA Medical News podcast, Felix Mahfoud, MD, chair of the Department of Cardiology at University Hospital Basel, shares clinical research highlights from the recent European Society of Cardiology Congress:
Listen now: ja.ma/42zYevz
Listen now: ja.ma/42zYevz
Cardiovascular Highlights From ESC 2025
Updates on GLP-1 drugs in heart failure, β-blockers after myocardial infarction, the shingles vaccine, and more: Felix Mahfoud, MD, chair of the Department of Cardiology at University Hospital Basel, shares clinical research highlights from the recent European Society of Cardiology Congress.
ja.ma
September 20, 2025 at 3:00 PM
In the latest episode of the JAMA Medical News podcast, Felix Mahfoud, MD, chair of the Department of Cardiology at University Hospital Basel, shares clinical research highlights from the recent European Society of Cardiology Congress:
Listen now: ja.ma/42zYevz
Listen now: ja.ma/42zYevz
Reposted by Joan Mancuso
“We can’t think about one anymore without the other,” says Martha Gulati, MD, MS, FACC on the link between treating the kidney and protecting the heart.
"We should aim to reduce the progression of chronic kidney diseases in order to reduce the possibility of heart disease." #ACCLATAM #ACCIntl
"We should aim to reduce the progression of chronic kidney diseases in order to reduce the possibility of heart disease." #ACCLATAM #ACCIntl
September 20, 2025 at 3:42 PM
Reposted by Joan Mancuso
One of the premier U.S. graduate fellowships is mired in uncertainty as would-be applicants await overdue details about how to apply for the upcoming year’s awards. https://scim.ag/4nlRhqc
Delays, uncertainty plague NSF fellowship for graduate students
After an unusual award process this year, applicants for next year are waiting for overdue guidelines
scim.ag
September 20, 2025 at 2:53 PM
One of the premier U.S. graduate fellowships is mired in uncertainty as would-be applicants await overdue details about how to apply for the upcoming year’s awards. https://scim.ag/4nlRhqc
Reposted by Joan Mancuso
World’s first AI-designed viruses a step towards AI-generated life. #Nature
Scientists used AI to write coherent viral genomes, using them to synthesize bacteriophages capable of killing resistant strains of bacteria.
www.nature.com/articles/d41...
Scientists used AI to write coherent viral genomes, using them to synthesize bacteriophages capable of killing resistant strains of bacteria.
www.nature.com/articles/d41...
World’s first AI-designed viruses a step towards AI-generated life
Scientists used AI to write coherent viral genomes, using them to synthesize bacteriophages capable of killing resistant strains of bacteria.
www.nature.com
September 20, 2025 at 5:46 PM
World’s first AI-designed viruses a step towards AI-generated life. #Nature
Scientists used AI to write coherent viral genomes, using them to synthesize bacteriophages capable of killing resistant strains of bacteria.
www.nature.com/articles/d41...
Scientists used AI to write coherent viral genomes, using them to synthesize bacteriophages capable of killing resistant strains of bacteria.
www.nature.com/articles/d41...
Reposted by Joan Mancuso
The 2022 ACC/AHA/HFSA #HeartFailure guideline provides patient-centric recommendations for clinicians to prevent, diagnose, & manage patients w/ heart failure.
Access the guideline, key takeaways, & more in the #JACC HF Guideline Hub: https://bit.ly/47T4JgI
#ACCLATAM #ACCIntl #CardioSky #MedSky
Access the guideline, key takeaways, & more in the #JACC HF Guideline Hub: https://bit.ly/47T4JgI
#ACCLATAM #ACCIntl #CardioSky #MedSky
September 20, 2025 at 5:55 PM
The 2022 ACC/AHA/HFSA #HeartFailure guideline provides patient-centric recommendations for clinicians to prevent, diagnose, & manage patients w/ heart failure.
Access the guideline, key takeaways, & more in the #JACC HF Guideline Hub: https://bit.ly/47T4JgI
#ACCLATAM #ACCIntl #CardioSky #MedSky
Access the guideline, key takeaways, & more in the #JACC HF Guideline Hub: https://bit.ly/47T4JgI
#ACCLATAM #ACCIntl #CardioSky #MedSky
Amping up TILs. Wish study would have included people with mTNBC. @KSQ_TX
ksqtx.com/press-releas...
ksqtx.com/press-releas...
KSQ Therapeutics Announces First Patient Dosed in Phase 1/2 Study for KSQ-004EX, a CRISPR/Cas9-Engineered Tumor Infiltrating Lymphocyte (eTIL®) Therapy - KSQ Therapeutics
Phase 1/2 clinical study will evaluate the safety and preliminary efficacy of KSQ-004EX in advanced solid tumors Lexington, Mass., April 9, 2025 — KSQ Therapeutics, Inc. (KSQ), a clinical-stage biotec...
ksqtx.com
September 14, 2025 at 1:42 PM
Amping up TILs. Wish study would have included people with mTNBC. @KSQ_TX
ksqtx.com/press-releas...
ksqtx.com/press-releas...